Organometal halide perovskite imager: a comparison 1.5 years after fabrication

Sarah Deumel; Albert J. J. M. van Breemen; Bart Peeters; Joris Maas; Hylke B. Akkerman; Eric A. Meulenkamp; Gerwin H. Gelinck; Judith E. Huerdler; Oliver Schmidt; Wolfgang Heiss; Sandro F. Tedde

doi:10.1117/12.2610586

Translator Disclaimer

4 April 2022 Organometal halide perovskite imager: a comparison 1.5 years after fabrication

Sarah Deumel, Albert J. J. M. van Breemen, Bart Peeters, Joris Maas, Hylke B. Akkerman, Eric A. Meulenkamp, Gerwin H. Gelinck, Judith E. Huerdler, Oliver Schmidt, Wolfgang Heiss, Sandro F. Tedde

Author Affiliations +

Proceedings Volume 12031, Medical Imaging 2022: Physics of Medical Imaging; 120310J (2022) https://doi.org/10.1117/12.2610586
Event: SPIE Medical Imaging, 2022, San Diego, California, United States

Abstract

The next generation medical imaging will benefit significantly from artificial intelligence – therefore, not only advances in computing power are required, but also further materials and technology improvements will lead to better image quality. The strong X-ray absorption, high charge carrier mobility and lifetime recommend perovskites like methylammonium lead triiodide (MAPbI3) as novel direct X-ray converting materials. A major obstacle to the commercialization is the limited stability and lifetime, as reported until now. Here, we show for the first time that degradation is limited in our X-ray detector after 1.5 years of storage in ambient conditions.

Conference Presentation

Citation Download Citation

Sarah Deumel, Albert J. J. M. van Breemen, Bart Peeters, Joris Maas, Hylke B. Akkerman, Eric A. Meulenkamp, Gerwin H. Gelinck, Judith E. Huerdler, Oliver Schmidt, Wolfgang Heiss, and Sandro F. Tedde "Organometal halide perovskite imager: a comparison 1.5 years after fabrication", Proc. SPIE 12031, Medical Imaging 2022: Physics of Medical Imaging, 120310J (4 April 2022); https://doi.org/10.1117/12.2610586

ACCESS THE FULL ARTICLE